Are metabolic (LCB) and innate immunity profiles associated with subclinical atherosclerosis in subjects with familial hypercholesterolemia?
Increased LCB and impaired innate immunity are independently associated with subclinical atherosclerosis in patients with familial hypercholesterolemia.
An increased LCB and an impaired innate immunity profile were found in FH subjects with subclinical atherosclerosis and they were independently associated with atherosclerotic injury. LCB could modulate the innate immunity profile.
Bosco et al. (Fri,) studied this question.